Peripartum cardiomyopathy, an obstetric complication: about a clinical case
Article Sidebar
Main Article Content
Abstract
Peripartum cardiomyopathy is a pathology with an atypical presentation that implies a challenge for the attending physician, both in diagnosis and treatment. The diagnosis is one of exclusion, so a woman with a clinical picture of heart failure in peripartum periodopathy must rule out other causes, such as pre-existing valve disease, acute myocardial infarction, pulmonary thromboembolism, and cardiodilation. Its treatment is based on the management of heart failure, in addition to hemodynamic support in patients who require intensive care. It is for this reason that we present below the clinical case of a 30-year-old female patient who was referred to our hospital, with a torpid evolution of her disease, with an unfavorable result.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
INVESTIGATIO es de acceso abierto y el contenido está disponible de manera gratuita a través de su sitio web: http://revistas.uees.edu.ec/index.php/IRR/.
Para reforzar nuestra política de acceso abierto, la revista INVESTIGATIO se publica bajo una licencia Creative Commons Reconocimiento-No Comercial 4.0 Internacional (CC-BY-NC 4.0), la cual permite compartir (copiar y redistribuir el material en cualquier medio o formato) y adaptar (remezclar, transformar y crear a partir del material), bajo la condición de que se den los créditos correspondientes y no se haga uso comercial de los materiales.
References
Arany, Z. (2018). Comprender el periparto Miocardiopatía. Annual Reviews & Knowable Magazine, 69, 165–176.
Arany, Z., & Elkayam, U. (2016). Peripartum cardiomyopathy. Circulation, 133(14), 1397–1409. https://doi.org/10.1161/CIRCULATIONAHA.115.020491
Asad, Z. U. A., Maiwand, M., Farah, F., & Dasari, T. W. (2018). Peripartum cardiomyopathy: A systematic review of the literature. Clinical Cardiology, 41(5), 693–697. https://doi.org/10.1002/clc.22932
Baris, L., Cornette, J., Johnson, M. R., Sliwa, K., & Roos-Hesselink, J. W. (2019). Peripartum cardiomyopathy: disease or syndrome? Heart, 105(5), 357–362. https://doi.org/10.1136/heartjnl-2018-314252
Bauersachs, J., König, T., van der Meer, P., Petrie, M. C., Hilfiker-Kleiner, D., Mbakwem, A., Hamdan, R., Jackson, A. M., Forsyth, P., de Boer, R. A., Mueller, C., Lyon, A. R., Lund, L. H., Piepoli, M. F., Heymans, S., Chioncel, O., Anker, S. D., Ponikowski, P., Seferovic, P. M., … Sliwa, K. (2019). Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure, 21(7), 827–843. https://doi.org/10.1002/ejhf.1493
Chinweuba, G. C., & Rutkofsky, I. H. (2020). Unveiling the Mystery of Peripartum Cardiomyopathy: A Traditional Review. Cureus, 12(10). https://doi.org/10.7759/cureus.10790
Davis, M. B., Arany, Z., McNamara, D. M., Goland, S., & Elkayam, U. (2020). Peripartum Cardiomyopathy: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 75(2), 207–221. https://doi.org/10.1016/j.jacc.2019.11.014
Duncker, D., Pfeffer, T. J., Bauersachs, J., & Veltmann, C. (2021). ECG y arritmias en la miocardiopatía periparto. Herzschrittmachertherapie + Elektrophysiologie, 32, pages207–213.
Gutiérrez-Abarca, L. (2021). Peripartum cardiomyopathy in 2021: what is available for its management? Revista Colombiana de Cardiologia, 28(6), 523–529. https://doi.org/10.24875/RCCAR.M21000093
Iorgoveanu, C., Zaghloul, A., & Ashwath, M. (2021). Miocardiopatía periparto: una revisión. Heart Failure Reviews, 0123456789.
Karaye, K. M., & Henein, M. Y. (2013). Peripartum cardiomyopathy: A review article. International Journal of Cardiology, 164(1), 33–38. https://doi.org/10.1016/j.ijcard.2011.11.069
Karchmer-Krivitzky S, 1 Espinosa-Fernández R, 2, Sánchez-Aranda A, 3 López-, Rioja MJ, 4, & D, M.-N. (2016). Miocardiopatía periparto : reporte de un caso report. Ginecol Obstet Mex., 84(8), 542–549.
Krause, M., Robbins, K. S., Almehlisi, A., Meier, Á., Almehlisi, A., Meier, A., & Schmidt, U. (2019). manuscrito aceptado. Journal of Cardiothoracic and Vascular Anesthesia, 33(10), 2814–2825.
Kryczka, K. E., Demkow, M., & Dzielinska, Z. (2021). Peripartum cardiomyopathy — a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives. Ginekologia Polska, 92(2), 147–152. https://doi.org/10.5603/GP.a2020.0171
Labbene, I., Arrigo, M., Tavares, M., Hajjej, Z., Brandão, J. L., Tolppanen, H., Feliot, E., Gayat, E., Ferjani, M., & Mebazaa, A. (2017). Decongestive effects of levosimendan in cardiogenic shock induced by postpartum cardiomyopathy. Anaesthesia Critical Care and Pain Medicine, 36(1), 39–42. https://doi.org/10.1016/j.accpm.2016.02.009
Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J. M., Gibbs, J. S. R., Gohlke-Baerwolf, C., Gorenek, B., Iung, B., Kirby, M., Maas, A. H. E. M., Morais, J., Nihoyannopoulos, P., Pieper, P. G., Presbitero, P., Roos-Hesselink, J. W., Schaufelberger, M., Seeland, U., … Warnes, C. (2011). ESC Guidelines on the management of cardiovascular diseases during pregnancy. European Heart Journal, 32(24), 3147–3197. https://doi.org/10.1093/eurheartj/ehr218
Sarraulte, G. V. (2017). Presentación de caso miocardiopatía periparto. 34(1).
Sliwa, K., Petrie, M. C., Van Der Meer, P., Mebazaa, A., Hilfiker-Kleiner, D., Jackson, A. M., Maggioni, A. P., Laroche, C., Regitz-Zagrosek, V., Schaufelberger, M., Tavazzi, L., Roos-Hesselink, J. W., Seferovic, P., Van Spaendonck-Zwarts, K., Mbakwem, A., Böhm, M., Mouquet, F., Pieske, B., Johnson, M. R., … Bauersachs, J. (2020). Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: An ESC EORP registry. European Heart Journal, 41(39), 3787–3797. https://doi.org/10.1093/eurheartj/ehaa455
Stergiopoulos, K., & Lima, F. V. (2019). Peripartum cardiomyopathy-diagnosis, management, and long term implications. Trends in Cardiovascular Medicine, 29(3), 164–173. https://doi.org/10.1016/j.tcm.2018.07.012